dr. A. Riezebos-Brilman

a.riezebos umcg.nl


  1. Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response

    van Wezel, E. M., de Bruijne, J., Damman, K., Bijmolen, M., van den Berg, A. P., Verschuuren, E. A. M., Ruigrok, G. A., Riezebos-Brilman, A. & Knoester, M., 1-Aug-2019, In : Open Forum Infectious Diseases. 6, 8, 4 p., 346.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Viral Hepatitis

    Niesters, H., Buter, C. & Brilman, A., 2016, Manual of molecular and clinical laboratory immunology. Detrick, B., Schmitz, J. L. & Hamilton, R. G. (eds.). 8 ed. Washington, DC: ASM Press, p. 620-638

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  3. Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens

    Milliken, E., de Zwart, A. E. S., Alffenaar, J-W. C., Marriott, D. J. E., Riezebos-Brilman, A., Schteinman, A., Evans, A. M., Glanville, A. R., Verschuuren, E. A. M. & Reuter, S. E., Mar-2019, In : Journal of Antimicrobial Chemotherapy. 74, 3, p. 691-698 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (28) »

View graph of relations

ID: 233522